• Haleon’s October 29, 2026, Q3 trading update call featured CEO Brian McNamara, CFO Dawn Allen and investor relations head Jo Russell.
• Quarterly growth missed expectations: weak North American cold-and-flu demand cost 40–50 basis points; China’s Centrum classification issue cost around 50 basis points.
• Management expects China’s Centrum disruption to persist through 2027; Brazil’s distribution changes will weigh on Q4 before supporting faster growth next year.
• The medium-term sales growth target remains 4%–6%, despite recent underperformance; management maintained its profit outlook while forecasting stronger growth in 2027.
• A share buyback was announced, with management retaining capacity for bolt-on acquisitions rather than pursuing a transformational deal.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HALEON plc published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.